114915-15-0

Basic information

• Product Name: N-Debenzoyl-7-{[(2,2,2,-trichloroethyl)oxy]carbonyl}paclitaxel
• Synonyms: N-Debenzoyl-7-{[(2,2,2,-trichloroethyl)oxy]carbonyl}paclitaxel;N-Debenzoyl-7-[[(2,2,2-trichloroethoxy)carbonyl]oxy]taxol
• CAS NO: 114915-15-0
• Molecular Formula: C₄₃H₄₈Cl₃NO₁₅
• Molecular Weight: 925.19792
• Product Categories: Amines;Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Amines, Aromatics, Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 114915-15-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Solubility: Ethyl Acetate, Methanol
• CAS DataBase Reference: N-Debenzoyl-7-{[(2,2,2,-trichloroethyl)oxy]carbonyl}paclitaxel(CAS DataBase Reference)
• NIST Chemistry Reference: N-Debenzoyl-7-{[(2,2,2,-trichloroethyl)oxy]carbonyl}paclitaxel(114915-15-0)
• EPA Substance Registry System: N-Debenzoyl-7-{[(2,2,2,-trichloroethyl)oxy]carbonyl}paclitaxel(114915-15-0)

Safety Data

• Hazardous Substances Data: 114915-15-0(Hazardous Substances Data)

Usage

Description

N-Debenzoyl-7-[(2,2,2,-trichloroethyl)oxy]carbonylpaclitaxel is a derivative of the well-known chemotherapeutic agent, paclitaxel (Taxol). It is a white solid with potent antitumor properties, making it a promising candidate for cancer treatment.

Uses

Used in Pharmaceutical Industry:
N-Debenzoyl-7-[(2,2,2,-trichloroethyl)oxy]carbonylpaclitaxel is used as an antineoplastic agent for the treatment of various types of cancer. It functions by disrupting the normal function of microtubules within cancer cells, leading to cell cycle arrest and apoptosis.
Used in Anticancer Applications:
As an antineoplastic agent, N-Debenzoyl-7-[(2,2,2,-trichloroethyl)oxy]carbonylpaclitaxel is employed to combat different types of cancer, including breast, ovarian, lung, and pancreatic cancers. It exhibits significant cytotoxic effects on cancer cells, making it a valuable addition to the arsenal of cancer-fighting drugs.
Used in Drug Development:
N-Debenzoyl-7-[(2,2,2,-trichloroethyl)oxy]carbonylpaclitaxel is also used in the development of novel drug formulations and delivery systems. Its unique chemical properties allow for the creation of innovative therapies that can potentially improve the efficacy and safety of cancer treatments.
Used in Research and Development:
In the field of research, N-Debenzoyl-7-[(2,2,2,-trichloroethyl)oxy]carbonylpaclitaxel serves as an important compound for studying the mechanisms of action of paclitaxel and its derivatives. This knowledge can be applied to the development of new anticancer drugs and the optimization of existing treatments.

Upstream product

• 114915-13-8 C₄₈H₅₆Cl₃NO₁₇ 
• 143527-73-5 C₅₁H₆₀Cl₃NO₁₇ 
• 103150-33-0 7-(2,2,2-trichloroethyloxycarbonyl)baccatin III 
• 27548-93-2 baccatin III 
• 32981-86-5 10-deacetylbaccatin III 
• 143615-00-3 (2R,3S)-3-amino-3-phenyl-2-hydroxypropionic acid ethyl ester 
• 144787-20-2 (2R,3S)-3-azido-2-hydroxy-benzenepropanoic acid ethyl ester 
• 100-52-7 benzaldehyde 
• 115437-18-8 7-triethylsilyl-10-deacetylbaccatin III 
• 126060-73-9 ethyl (2R,3R)-3-phenyl-2,3-oxiranepropanoate 
• 143527-75-7 (2R,3S) ethyl N-(t-butoxycarbonyl)-3-phenylisoserine 
• 143615-03-6 (4S,5R)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid 
• 143527-74-6 ethyl (4S,5R)-3-tert-butoxycarbonyl-2,2-dimethyl-4-phenyl-5-oxazolidinecarboxylate 
• 144704-63-2 (4S,5R)-3-((2S,3R)-2-Bromo-3-hydroxy-3-phenyl-propionyl)-4-methyl-5-phenyl-oxazolidin-2-one 

Downstream Products

• 114915-17-2 C₅₀H₅₂Cl₃NO₁₆ 
• 1054642-58-8 C₆₅H₆₆Cl₆N₂O₂₀ 
• 1053611-06-5 C₆₀H₆₄N₂O₁₈ 
• 33069-62-4 taxol 

Relevant articles and documents

Design and synthesis of a taxoid library using radiofrequency encoded combinatorial chemistry

Radiofrequency encoded combinatorial (REC) chemistry is a recently developed nonchemical encoding strategy in library synthesis. Encoded chemical libraries of complex molecular structures like Taxol can be constructed employing the noninvasive REC strategy and novel solid phase synthesis techniques, as demonstrated by the synthesis of the first 400- membered taxoid library in a discrete format and in quantities of multimilligrams/member.

Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues

-